164 related articles for article (PubMed ID: 38551814)
41. Thevebioside, the active ingredient of traditional Chinese medicine, promotes ubiquitin-mediated SRC-3 degradation to induce NSCLC cells apoptosis.
Yao C; Su L; Zhang F; Zhu X; Zhu Y; Wei L; Jiao X; Hou Y; Chen X; Wang W; Wang J; Zhu X; Zou C; Zhu S; Xu Z
Cancer Lett; 2020 Nov; 493():167-177. PubMed ID: 32829007
[TBL] [Abstract][Full Text] [Related]
42. Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.
Karmakar S; Gao T; Pace MC; Oesterreich S; Smith CL
Mol Endocrinol; 2010 Jun; 24(6):1187-202. PubMed ID: 20392877
[TBL] [Abstract][Full Text] [Related]
43. The steroid receptor coactivator-3 is required for the development of castration-resistant prostate cancer.
Tien JC; Liu Z; Liao L; Wang F; Xu Y; Wu YL; Zhou N; Ittmann M; Xu J
Cancer Res; 2013 Jul; 73(13):3997-4008. PubMed ID: 23650284
[TBL] [Abstract][Full Text] [Related]
44. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1.
Wang Y; Lonard DM; Yu Y; Chow DC; Palzkill TG; Wang J; Qi R; Matzuk AJ; Song X; Madoux F; Hodder P; Chase P; Griffin PR; Zhou S; Liao L; Xu J; O'Malley BW
Cancer Res; 2014 Mar; 74(5):1506-1517. PubMed ID: 24390736
[TBL] [Abstract][Full Text] [Related]
45. SRC-3 coactivator regulates cell resistance to cytotoxic stress via TRAF4-mediated p53 destabilization.
Yi P; Xia W; Wu RC; Lonard DM; Hung MC; O'Malley BW
Genes Dev; 2013 Feb; 27(3):274-87. PubMed ID: 23388826
[TBL] [Abstract][Full Text] [Related]
46. Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation-Drug leads for metastatic castration resistant prostate cancer.
Fancher AT; Hua Y; Close DA; Xu W; McDermott LA; Strock CJ; Santiago U; Camacho CJ; Johnston PA
SLAS Discov; 2023 Oct; 28(7):325-343. PubMed ID: 37549772
[TBL] [Abstract][Full Text] [Related]
47. Synthesis, in vitro anticancer activity and in silico studies of certain isoxazole-based carboxamides, ureates, and hydrazones as potential inhibitors of VEGFR2.
Abou-Seri SM; Eissa AAM; Behery MGM; Omar FA
Bioorg Chem; 2021 Nov; 116():105334. PubMed ID: 34534755
[TBL] [Abstract][Full Text] [Related]
48. Peptidomimetic Src/pretubulin inhibitor KX-01 alone and in combination with paclitaxel suppresses growth, metastasis in human ER/PR/HER2-negative tumor xenografts.
Anbalagan M; Ali A; Jones RK; Marsden CG; Sheng M; Carrier L; Bu Y; Hangauer D; Rowan BG
Mol Cancer Ther; 2012 Sep; 11(9):1936-47. PubMed ID: 22784709
[TBL] [Abstract][Full Text] [Related]
49. Preclinical Evaluation of a Novel Orally Available SRC/Raf/VEGFR2 Inhibitor, SKLB646, in the Treatment of Triple-Negative Breast Cancer.
Zheng MW; Zhang CH; Chen K; Huang M; Li YP; Lin WT; Zhang RJ; Zhong L; Xiang R; Li LL; Liu XY; Wei YQ; Yang SY
Mol Cancer Ther; 2016 Mar; 15(3):366-78. PubMed ID: 26721945
[TBL] [Abstract][Full Text] [Related]
50. Discovery and cellular stress pathway analysis of 1,4-naphthoquinone derivatives with novel, highly potent broad-spectrum anticancer activity.
Ghosh SK; Ganta A; Spanjaard RA
J Biomed Sci; 2018 Feb; 25(1):12. PubMed ID: 29422060
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and Investigation of the Role of Benzopyran Dihydropyrimidinone Hybrids in Cell Proliferation, Migration and Tumor Growth.
Dash AK; Nayak D; Hussain N; Mintoo MJ; Bano S; Katoch A; Mondhe DM; Goswami A; Mukherjee D
Anticancer Agents Med Chem; 2019; 19(2):276-288. PubMed ID: 30179143
[TBL] [Abstract][Full Text] [Related]
52. Development of the phenylpyrazolo[3,4-
Lee HJ; Pham PC; Pei H; Lim B; Hyun SY; Baek B; Kim B; Kim Y; Kim MH; Kang NW; Min HY; Kim DD; Lee J; Lee HY
Theranostics; 2021; 11(4):1918-1936. PubMed ID: 33408789
[No Abstract] [Full Text] [Related]
53. FBXL16 modulates the proliferation and autophagy in breast cancer cells via activating SRC-3-AKT signaling pathway.
Yang M; Jing F
Reprod Biol; 2021 Sep; 21(3):100538. PubMed ID: 34333223
[TBL] [Abstract][Full Text] [Related]
54. Targeted inhibition of Src kinase with dasatinib blocks thyroid cancer growth and metastasis.
Chan CM; Jing X; Pike LA; Zhou Q; Lim DJ; Sams SB; Lund GS; Sharma V; Haugen BR; Schweppe RE
Clin Cancer Res; 2012 Jul; 18(13):3580-91. PubMed ID: 22586301
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis, and biological evaluation of novel benzodiazepine derivatives as anticancer agents through inhibition of tubulin polymerization in vitro and in vivo.
Pang Y; Lin H; Ou C; Cao Y; An B; Yan J; Li X
Eur J Med Chem; 2019 Nov; 182():111670. PubMed ID: 31499359
[TBL] [Abstract][Full Text] [Related]
56. Structure-based optimization leads to the discovery of NSC765844, a highly potent, less toxic and orally efficacious dual PI3K/mTOR inhibitor.
Han J; Chen Y; Yang C; Liu T; Wang M; Xu H; Zhang L; Zheng C; Song Y; Zhu J
Eur J Med Chem; 2016 Oct; 122():684-701. PubMed ID: 27448924
[TBL] [Abstract][Full Text] [Related]
57. Estradiol increases cell growth in human astrocytoma cell lines through ERα activation and its interaction with SRC-1 and SRC-3 coactivators.
González-Arenas A; Hansberg-Pastor V; Hernández-Hernández OT; González-García TK; Henderson-Villalpando J; Lemus-Hernández D; Cruz-Barrios A; Rivas-Suárez M; Camacho-Arroyo I
Biochim Biophys Acta; 2012 Feb; 1823(2):379-86. PubMed ID: 22142990
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and Anticancer Activity of Novel Indole Derivatives as Dual EGFR/SRC Kinase Inhibitors.
Olgen S; Biltekin Kaleli SN; Karaca BT; Demirel UU; Bristow HK
Curr Med Chem; 2023 Jun; ():. PubMed ID: 37365789
[TBL] [Abstract][Full Text] [Related]
59. Design, Synthesis, Structure-Activity Relationship and Docking Studies of Novel Functionalized Arylvinyl-1,2,4-Trioxanes as Potent Antiplasmodial as well as Anticancer Agents.
Tiwari MK; Coghi P; Agrawal P; Shyamlal BRK; Jun Yang L; Yadav L; Peng Y; Sharma R; Yadav DK; Sahal D; Kam Wai Wong V; Chaudhary S
ChemMedChem; 2020 Jul; 15(13):1216-1228. PubMed ID: 32392362
[TBL] [Abstract][Full Text] [Related]
60. In vitro and in vivo anticancer potential and molecular targets of the new colchicine analog IIIM-067.
Malik S; Mintoo MJ; Reddy CN; Kumar R; Kotwal P; Bharate SB; Nandi U; Mondhe DM; Shukla SK
J Integr Med; 2023 Jan; 21(1):62-76. PubMed ID: 36253285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
